PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 100.60
Bid: 100.60
Ask: 100.80
Change: -0.20 (-0.20%)
Spread: 0.20 (0.199%)
Open: 100.40
High: 101.20
Low: 100.40
Prev. Close: 100.80
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion to Investment Trust Company

1 Apr 2021 07:00

RNS Number : 2233U
Hipgnosis Songs Fund Limited
01 April 2021
 

1 April 2021

 

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Conversion to investment trust company

The Board of Hipgnosis Songs Fund Limited, the first UK listed investment company offering investors a pure-play exposure to songs and associated intellectual property rights, and its Investment Adviser, The Family (Music) Limited, are pleased to announce that, as noted in the Company's prospectus dated 21 January 2021 (the "Prospectus"), the Company applied to HMRC for approval of the Company as an investment trust company and that such approval has been granted. Accordingly, the Company's conversion to an investment trust company will take effect from today (and for such time as the Company maintains this status). The Company will be treated as being resident in the UK for tax purposes from such date. With effect from this change, the Company will cease to be a Guernsey tax exempt vehicle under The Income Tax (Exempt Bodies) (Guernsey) Ordinance, 1989, as amended.

 

The Company applied to become an investment trust company to mitigate the recently increased scope of Guernsey's economic substance rules, which now apply to Guernsey entities (including Guernsey tax exempt vehicles) that are self-managed collective investment schemes.

 

In respect of each accounting period for which the Company is approved by HMRC as an investment trust, the Company will be exempt from UK taxation on its chargeable gains. The Company will, however, (subject to what follows) be liable to UK corporation tax on its income in the normal way. The Company should, in practice, be exempt from UK corporation tax on dividend income received, provided that such dividends (whether from UK or non UK companies) fall within one of the "exempt classes" in Part 9A of the Corporation Tax Act 2009. 

 

Details of the tax implications for UK resident shareholders are outlined in paragraph 2 of Part VI (Taxation) of the Prospectus, and details of the ongoing conditions for investment trust companies are outlined in paragraphs 1.5 and 1.6 of Paragraph VII (Additional Information) of the Prospectus. If shareholders are in any doubt about their tax position, they should consult their professional adviser.

 

 

For further information, please contact:

The Family (Music) Limited

Merck Mercuriadis

 

Tel: +44 (0)1481 742742

N+1 Singer - Joint Corporate Broker

James Maxwell / James Moat / Amanda Gray (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)

 

Tel: +44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

 

Tel: +44 (0)20 7742 4000

RBC Capital Markets - Joint Corporate Broker

Will Smith / Elliot Thomas / Lauren Davies (Corporate Finance)

Lisa Tugwell (Sales)

 

Tel: +44 (0)20 7635 4000

Ocorian - Company Secretary & Administrator

Julian Carey

 

Tel: +44 (0) 1481 742742

The Outside Organisation

Alan Edwards / Nick Caley

Tel: +44 (0)7711 081 843

 

FTI Consulting

Neil Doyle/ Paul Harris/ Laura Ewart

 

 

Tel: +44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646

 

All US music publicity enquiries

Fran Defeo

+1 917 767 5255

 

NOTES TO EDITORS

 

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of over £1.1 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020 and February 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index.

 

About The Family (Music) Limited

The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, Nick Jarjour, David A. Stewart, Bill Leibowitz, Ian Montone, Rodney Jerkins, Bjorn Lindvall and Chris Helm.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUCWWUPGPGG
Date   Source Headline
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSDirectorate Changes
6th Nov 20237:00 amRNSUpdate on dividend intentions
26th Oct 202311:20 amRNSResult of AGM and EGM
25th Oct 20234:00 pmRNSDirectorate Changes, withdrawal of AGM Resolutions
24th Oct 20237:00 amRNSConclusion of Go-Shop process
19th Oct 20237:00 amRNSInitiation of Strategic Review, update on RCF
17th Oct 202312:22 pmRNSHolding(s) in Company
17th Oct 202312:21 pmRNSHolding(s) in Company
17th Oct 202312:18 pmRNSHolding(s) in Company
16th Oct 20236:17 pmRNSUpdate on CRB III and dividend payment
16th Oct 20237:13 amRNSUpdate on CRB III impact and dividend payment
28th Sep 202311:07 amRNSPublication of Circular and Notice of AGM & EGM
25th Sep 20232:41 pmRNSHolding(s) in Company
22nd Sep 202310:49 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSDividend Declaration
20th Sep 20237:00 amRNSHolding(s) in Company
14th Sep 20237:00 amRNSAsset sales to fund buy backs and reduce debt
14th Aug 202312:29 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration
16th May 20237:00 amRNSCorrection of Director/PDMR Shareholding
15th May 20234:32 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights
23rd Dec 202211:53 amRNSPublication of Factsheet
13th Dec 20224:03 pmRNSHoldings in Company-Notification of Major Holdings
8th Dec 20227:01 amRNSDividend Declaration
8th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202210:05 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSNotice: Half Year Results and Capital Markets Day
24th Nov 20226:06 pmRNSHolding(s) in Company
18th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20223:29 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:01 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:35 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20223:16 pmRNSReplacement Transaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.